Compounds > cephalosporin c

Page last updated: 2024-08-24

cephalosporin c and fleroxacin

cephalosporin c has been researched along with fleroxacin in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (38.89)	18.7374
1990's	11 (61.11)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA	2
Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA	1
Bartlett, RC; Mazens-Sullivan, MF; McCarter, YS	1
Bertasso, A; Georgopapadakou, NH; Pace, J	1
Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J	1
Daschner, F; Kropec, A	1
Bertasso, A; Chan, KK; Chapman, JS; Cleeland, R; Cummings, LM; Dix, BA; Georgopapadakou, NH; Keith, DD	1
Beskid, G; Chan, K; Cleeland, R; Fallat, V; Keith, DD; Lipschitz, ER; McGarry, DH; Unowsky, J	1
Brunham, RC; Le Saux, NM; Plummer, FA; Ronald, AR; Slaney, LA	1
Easmon, CS; Ison, CA; Woodford, N	1
Hohl, P; Kafader, FM; Salfinger, M	1
Hardegger, U; Wüst, J	1
Jones, RN; Sanchez, ML	1
Appelbaum, PC; Jacobs, MR; Pankuch, GA; Spangler, SK	1
Cunningham, B; Nickerson, B; Scypinski, S	1
Barreca, GS; Berlinghieri, MC; Focà, A; Foti, F; Matera, G	1
Agneter, E; Burgdorff, T; Eichler, HG; Georgopoulos, A; Haag, O; Jansen, B; Müller, M; Pehamberger, H; Stanek, G; Weninger, W	1

Trials

1 trial(s) available for cephalosporin c and fleroxacin

Article	Year
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:12 Topics: Adipose Tissue; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cefpirome; Cellulitis; Cephalosporins; Erythromycin; Female; Fleroxacin; Humans; Macrolides; Male; Microdialysis; Muscle, Skeletal; Skin	1996

Other Studies

17 other study(ies) available for cephalosporin c and fleroxacin

Article	Year
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin. Journal of clinical microbiology, 1992, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin	1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin. Journal of clinical microbiology, 1992, Volume: 30, Issue:3 Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin	1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin. Journal of clinical microbiology, 1992, Volume: 30, Issue:5 Topics: Anti-Infective Agents; Cefdinir; Ceftizoxime; Cephalosporins; Diffusion; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Quinolones	1992
The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents. Chemotherapy, 1992, Volume: 38, Issue:5 Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones	1992
Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cell Membrane Permeability; Cephalosporins; Ciprofloxacin; Coliphages; DNA Replication; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Fluoroquinolones; Gene Expression Regulation, Bacterial; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Porins	1991
Cephalosporin 3'-quinolone esters with a dual mode of action. Journal of medicinal chemistry, 1990, Volume: 33, Issue:1 Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship	1990
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus. Chemotherapy, 1989, Volume: 35, Issue:5 Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin	1989
Mode of action of the dual-action cephalosporin Ro 23-9424. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7 Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cephalosporins; Ciprofloxacin; DNA Replication; DNA, Bacterial; Enterobacter; Escherichia coli; Fleroxacin; Fluoroquinolones; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus	1989
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7 Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Pseudomonas	1989
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:7 Topics: Cefmenoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Erythromycin; Fleroxacin; Haemophilus ducreyi; Humans; Neisseria gonorrhoeae; Penicillins; Spectinomycin; Tetracycline	1987
The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci. The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:6 Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Neisseria gonorrhoeae; Penicillin Resistance	1987
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae. European journal of clinical microbiology, 1987, Volume: 6, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1987
Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria. European journal of clinical microbiology, 1987, Volume: 6, Issue:6 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Humans	1987
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534. Diagnostic microbiology and infectious disease, 1994, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure	1994
Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:2 Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Culture Media; Fleroxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae	1993
The use of capillary electrophoresis to monitor the stability of a dual-action cephalosporin in solution. Journal of pharmaceutical and biomedical analysis, 1995, Volume: 14, Issue:1-2 Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Drug Stability; Electrophoresis, Capillary; Fleroxacin; Fluoroquinolones; Half-Life; Kinetics; Solutions; Water	1995
Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:5 Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Fleroxacin; Fluoroquinolones; Humans; Interleukin-1; Interleukin-8; Lipopolysaccharides; Monocytes; Neutrophils; Phagocytosis; Superoxides; Tumor Necrosis Factor-alpha	1996